{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:08:55Z","timestamp":1789614535063,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30973188"],"award-info":[{"award-number":["30973188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.bbrc.2014.01.053","type":"journal-article","created":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T19:20:11Z","timestamp":1390418411000},"page":"376-381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Dihydroartemisinin potentiates the anticancer effect of cisplatin via mTOR inhibition in cisplatin-resistant ovarian cancer cells: involvement of apoptosis and autophagy"],"prefix":"10.1016","volume":"444","author":[{"given":"Xue","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.01.053_b0005","first-page":"169","article-title":"Progress in the research of artemisinin and its analogues as antimalarials: an update","volume":"16","author":"Sriram","year":"2004","journal-title":"Pharm. World Sci."},{"key":"10.1016\/j.bbrc.2014.01.053_b0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0024-3205(99)00356-2","article-title":"Current status of artemisinin and its derivatives as antimalarial drugs","volume":"66","author":"Dhingra","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2014.01.053_b0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.canlet.2010.01.001","article-title":"Dihydroartemisinin inactivates NF-kB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo","volume":"293","author":"Wang","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2014.01.053_b0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11010-011-0716-6","article-title":"Anti-tumor effects of dihydroartemisinin on human osteosarcoma","volume":"351","author":"Ji","year":"2011","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.bbrc.2014.01.053_b0025","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/030089161109700615","article-title":"Dihydroartemisinin induces endoplasmic reticulum stress-mediated apoptosis in HepG2 human hepatoma cells","volume":"97","author":"Gao","year":"2011","journal-title":"Tumori"},{"key":"10.1016\/j.bbrc.2014.01.053_b0030","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3322\/caac.20121","article-title":"Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths","volume":"61","author":"Siegel","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2014.01.053_b0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.7-suppl_5-20","article-title":"Relapsed ovarian cancer: challenges and management strategies for a chronic disease","volume":"7","author":"Armstrong","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.bbrc.2014.01.053_b0040","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1038\/sj.onc.1207521","article-title":"Autophagy as a cell death and tumor suppressor mechanism","volume":"23","author":"Gozuacik","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2014.01.053_b0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ccr.2009.07.004","article-title":"Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells","volume":"16","author":"Tormo","year":"2009","journal-title":"Cancer Cell."},{"key":"10.1016\/j.bbrc.2014.01.053_b0050","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/cdd.2010.191","article-title":"The Beclin 1 network regulates autophagy and apoptosis","volume":"18","author":"Kang","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbrc.2014.01.053_b0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10911-012-9264-2","article-title":"Targeting the PI3K\/Akt\/mTOR pathway for breast cancer therapy","volume":"17","author":"Cidado","year":"2012","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.bbrc.2014.01.053_b0060","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ijc.26396","article-title":"MTOR as a therapeutic target in patients with gastric cancer","volume":"130","author":"Al-Batran","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2014.01.053_b0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4046\/trd.2013.75.1.9","article-title":"Autophagy inhibition with monensin enhances cell cycle arrest and apoptosis induced by mTOR or epidermal growth factor receptor inhibitors in lung cancer cells","volume":"75","author":"Choi","year":"2013","journal-title":"Tuberc. Respir. Dis."},{"key":"10.1016\/j.bbrc.2014.01.053_b0070","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.bcp.2012.07.012","article-title":"Dietary flavonoid fisetin: a novel dual inhibitor of PI3K\/Akt and mTOR for prostate cancer management","volume":"84","author":"Adhami","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2014.01.053_b0075","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s10147-012-0459-8","article-title":"Clinical trials and future potential of targeted therapy for ovarian cancer","volume":"17","author":"Itamochi","year":"2012","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2014.01.053_b0080","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.2174\/092986711796150450","article-title":"Targeting mTOR signaling pathway in ovarian cancer","volume":"18","author":"Mabuchi","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbrc.2014.01.053_b0085","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1517\/13543780903321508","article-title":"The rationale for mTOR inhibition in epithelial ovarian cancer","volume":"18","author":"Trinh","year":"2009","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.bbrc.2014.01.053_b0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1247\/csf.23.33","article-title":"Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells","volume":"23","author":"Yamamoto","year":"1998","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.bbrc.2014.01.053_b0095","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.4161\/auto.21376","article-title":"Autophagy is a protective response to ethanol neurotoxicity","volume":"8","author":"Chen","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.bbrc.2014.01.053_b0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1586\/era.09.167","article-title":"First-line treatment of advanced ovarian cancer: current research and perspectives","volume":"10","author":"Marchetti","year":"2010","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.bbrc.2014.01.053_b0105","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1211\/jpp.59.6.0011","article-title":"Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1alpha activation in C6 glioma cells","volume":"59","author":"Huang","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bbrc.2014.01.053_b0110","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10495-011-0580-6","article-title":"Interruption of the MEK\/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo","volume":"16","author":"Gao","year":"2011","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbrc.2014.01.053_b0115","first-page":"101","article-title":"Dihydroartiminisin inhibits the growth and metastasis of epithelial ovarian cancer","volume":"27","author":"Wu","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2014.01.053_b0120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2014.01.053_b0125","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1074\/jbc.M309999200","article-title":"AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression","volume":"279","author":"Gera","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.01.053_b0130","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1101\/gad.1662308","article-title":"Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK","volume":"22","author":"Dan","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2014.01.053_b0135","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00018-002-8510-y","article-title":"Cyclin A in cell cycle control and cancer","volume":"59","author":"Yam","year":"2002","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2014.01.053_b0140","first-page":"214","article-title":"Bcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy\/apoptosis toggle switch","volume":"2","author":"Marquez","year":"2012","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bbrc.2014.01.053_b0145","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/dna.2013.2003","article-title":"Both PI3K- and mTOR-signaling pathways take part in CVB3-induced apoptosis of Hela cells","volume":"32","author":"Li","year":"2013","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.bbrc.2014.01.053_b0150","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","article-title":"Methods in mammalian autophagy research","volume":"140","author":"Mizushima","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2014.01.053_b0155","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.4161\/auto.7.9.16521","article-title":"Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development","volume":"7","author":"Sun","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.bbrc.2014.01.053_b0160","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4161\/auto.7.5.15066","article-title":"Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics","volume":"7","author":"O\u2019Donovan","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.bbrc.2014.01.053_b0165","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1242\/jcs.03349","article-title":"Metabolic catastrophe as a means to cancer cell death","volume":"120","author":"Jin","year":"2007","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbrc.2014.01.053_b0170","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cell.2009.03.048","article-title":"Autophagy suppresses tumorigenesis through elimination of p62","volume":"37","author":"Mathew","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2014.01.053_b0175","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.febslet.2010.01.017","article-title":"MTOR regulation of autophagy","volume":"584","author":"Jung","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2014.01.053_b0180","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1091\/mbc.01-05-0272","article-title":"Activation and caspase mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling","volume":"13","author":"Los","year":"2002","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbrc.2014.01.053_b0185","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bbrc.2009.08.007","article-title":"Activation of autophagy during glutamate-induced HT22 cell death","volume":"388","author":"Kim","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2014.01.053_b0190","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00005-012-0205-y","article-title":"Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer","volume":"61","author":"Chaabane","year":"2013","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14000771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14000771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T22:46:07Z","timestamp":1565131567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14000771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0006291X14000771"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.01.053","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dihydroartemisinin potentiates the anticancer effect of cisplatin via mTOR inhibition in cisplatin-resistant ovarian cancer cells: involvement of apoptosis and autophagy","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.01.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}